| Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon (NCT05685875) | Karolinska Institutet | 2022-06-07 |
| Plasmodium Vivax Among Duffy Negative Population in Cameroon. (NCT05058885) | University of Dschang | 2022-05-02 |
| PfSPZ Vaccine Trial in Malian Children (NCT04940130) | Sanaria Inc. | 2022-04-01 |
| Comparing Chemoprevention Approaches for School-based Malaria Control (NCT05244954) | University of Maryland, Baltimore | 2022-02-01 |
| Effect of Paracetamol on Kidney Function in Severe Malaria (NCT04251351) | University of British Columbia | 2021-12-13 |
| MSP3-CRM-Vac4All/ Alhydrogel® Malaria Vaccine (NCT05197751) | Vac4All | 2021-12-01 |
| Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali (NCT05135273) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-10-22 |
| Plasmodium Falciparum Genomic Intelligence in Mozambique (NCT05306067) | Centro de Investigacao em Saude de Manhica | 2021-10-12 |
| Association Between Drug Levels, Malaria, and Antimalarial Resistance in the Setting of Seasonal Malaria Chemoprevention (NCT04969185) | University of California, San Francisco | 2021-08-16 |
| Evaluation of Insecticide-treated Eave Nets and Window Screens for Malaria Control in Tanzania. (NCT05125133) | Ifakara Health Institute | 2021-07-09 |
| Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities (NCT04864444) | University of California, San Francisco | 2021-06-19 |
| Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania. (NCT04271306) | University of Oxford | 2021-05-25 |
| Adjunctive Ivermectin Mass Drug Administration for Malaria Control (NCT04844905) | London School of Hygiene and Tropical Medicine | 2021-05-03 |
| Proactive Community Case Management for Malaria in Zambia (NCT04839900) | PATH | 2021-04-15 |
| Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria (NCT04709692) | R. Kiplin Guy | 2021-04-14 |
| Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR Congo (NCT04289688) | Institute of Tropical Medicine, Belgium | 2021-02-01 |
| Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in Children (NCT04473768) | Institute of Tropical Medicine, Belgium | 2021-02-01 |
| Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania (NCT04318002) | University of Oxford | 2021-01-21 |
| Attractive Targeted Sugar Bait Phase III Trial in Zambia (NCT04800055) | PATH | 2020-12-01 |
| Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2) (NCT04609098) | London School of Hygiene and Tropical Medicine | 2020-10-29 |
| Vectron T500 (Broflanilide 50WP) for IRS in Tanzania Tanzania (NCT05150808) | London School of Hygiene and Tropical Medicine | 2020-10-01 |
| Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya (NCT07362498) | Strathmore University | 2020-06-01 |
| Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study (NCT04319380) | London School of Hygiene and Tropical Medicine | 2020-04-01 |
| Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites (NCT04310085) | Medicines for Malaria Venture | 2020-02-19 |
| Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F (NCT04238689) | Radboud University Medical Center | 2020-02-14 |
| VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine (NCT04130282) | University of Oxford | 2019-09-27 |
| Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission (NCT04049916) | London School of Hygiene and Tropical Medicine | 2019-09-12 |
| Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+Amodiaquin (NCT04149106) | University Clinical Research Center, Mali | 2019-07-01 |
| Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde (NCT04565184) | University of Yaounde 1 | 2019-05-09 |
| Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso (NCT03896724) | University of Oxford | 2019-05-07 |
| A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants (NCT03580824) | University of Oxford | 2019-04-30 |
| Safety and Efficacy of NF135 CPS Immunization (NCT03813108) | Radboud University Medical Center | 2019-04-01 |
| Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania (NCT03640403) | National Institute for Medical Research, Tanzania | 2019-03-26 |
| To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers (NCT03867331) | VLP Therapeutics | 2019-03-13 |
| Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 (NCT03882528) | U.S. Army Medical Research and Development Command | 2019-03-04 |
| Malaria Vaccine Pilot Evaluation (NCT03806465) | Rafiq OKINE | 2019-02-25 |
| Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua (NCT06036030) | Syamsudin Abdillah,Ph.D, Pharm D | 2019-01-11 |
| Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections (NCT03814616) | Shin Poong Pharmaceutical Co. Ltd. | 2018-10-03 |
| Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2 (NCT03454048) | Radboud University Medical Center | 2018-05-07 |
| Safety and Immunogenicity of ChAd63 RH5 and MVA RH5 in Adults, Young Children and Infants Living in Tanzania (NCT03435874) | University of Oxford | 2018-04-12 |
| Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam (NCT03355664) | University of Oxford | 2018-03-19 |
| Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults (NCT03420053) | Sanaria Inc. | 2018-02-07 |
| Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE) (NCT03178643) | Duke University | 2018-01-23 |
| Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model (NCT03195387) | Medicines for Malaria Venture | 2018-01-01 |
| Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections (NCT03511443) | University Research Co, LLC | 2017-10-02 |
| "Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania" (NCT03241901) | Muhimbili University of Health and Allied Sciences | 2017-07-27 |
| Cohort Event Monitoring Study of Pyramax® (NCT03201770) | Shin Poong Pharmaceutical Co. Ltd. | 2017-06-22 |
| Non-specific Effects of Vaccination on Mortality and Morbidity (NCT03176719) | Radboud University Medical Center | 2017-06-17 |
| Safety and Protective Efficacy of Pb(PfCS@UIS4) (NCT03138096) | Radboud University Medical Center | 2017-05-29 |
| Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) (NCT03143218) | London School of Hygiene and Tropical Medicine | 2017-04-17 |
| TES of Artemether-lumefantrine for Pf in the Philippines in 2017-2018 (NCT05958810) | Research Institute for Tropical Medicine, Philippines | 2017-01-02 |
| Methylene Blue Against Falciparum Malaria in Burkina Faso (NCT02851108) | Heidelberg University | 2016-10-01 |
| Therapeutic Efficacy Study of AL and DP in Western Kenya (NCT05060198) | Kenya Medical Research Institute | 2016-06-17 |
| A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607 (NCT02737007) | GlaxoSmithKline | 2016-04-18 |
| Malawi International Center of Excellence in Malaria Research School-based Cohort (NCT04858087) | University of Maryland, Baltimore | 2015-03-24 |
| TES of Artemether-lumefantrine for Pf in the Philippines in 2015 (NCT05958693) | Research Institute for Tropical Medicine, Philippines | 2015-01-05 |
| Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia (NCT02325180) | London School of Hygiene and Tropical Medicine | 2015-01-01 |
| Safety and Tolerability of Low Dose Primaquine (NCT02434952) | Malaria Consortium | 2014-10-01 |
| Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia (NCT02329301) | PATH | 2014-09-01 |
| Assessment of Artesunate/Mefloquine in the Peruvian Amazon (NCT02084602) | Instituto Nacional de Salud. Peru | 2014-06-18 |
| In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria (NCT02637128) | Centers for Disease Control and Prevention | 2014-03-01 |
| Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL) (NCT02448745) | The Mentor Initiative | 2014-03-01 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO (NCT01930331) | Ifakara Health Institute | 2014-01-07 |
| Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults (NCT02014727) | Institut National de la Santé Et de la Recherche Médicale, France | 2014-01-01 |
| Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics and Population Pharmacokinetics (NCT01944189) | Makerere University | 2013-09-01 |
| Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis (NCT01783340) | Radboud University Medical Center | 2013-04-01 |
| Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya (NCT02987270) | Simon Kariuki | 2013-04-01 |
| Malaria Transmission Studies in Mali (NCT01829737) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-20 |
| Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites (NCT01660854) | Radboud University Medical Center | 2012-07-01 |
| Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria (NCT01442168) | Modus Therapeutics AB | 2011-09-01 |
| Time to Become Negative of Three Rapid Diagnostic Tests for Malaria (NCT01325974) | Epicentre | 2011-09-01 |
| Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi (NCT01326754) | Centers for Disease Control and Prevention | 2011-08-01 |
| Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection (NCT01213966) | Medicines for Malaria Venture | 2010-10-01 |
| Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity (NCT01160562) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-06-23 |
| Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma (NCT01163877) | Swiss Federal Institute of Technology | 2010-04-01 |
| Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers (NCT01222962) | sigma-tau i.f.r. S.p.A. | 2010-03-01 |
| A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™ (NCT01222949) | sigma-tau i.f.r. S.p.A. | 2010-02-01 |
| Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers (NCT01103830) | sigma-tau i.f.r. S.p.A. | 2010-02-01 |
| Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania (NCT00885287) | University of Copenhagen | 2009-07-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects (NCT00928083) | Medicines for Malaria Venture | 2009-04-01 |
| Study of Iron Absorption and Utilization in Asymptomatic Malaria (NCT01108939) | Swiss Federal Institute of Technology | 2009-02-01 |
| Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa (NCT00677833) | Pfizer | 2008-06-01 |
| Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria (NCT01567423) | Epicentre | 2008-04-01 |
| Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria (NCT00529867) | Dafra Pharma | 2007-05-01 |
| Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau (NCT00426439) | Bandim Health Project | 2006-12-01 |
| Artemisinin Resistance in Cambodia (NCT00479206) | Medical University of Vienna | 2006-10-01 |
| Randomized Trial on Effectiveness of ACTs in Ghana (NCT00374205) | Bernhard Nocht Institute for Tropical Medicine | 2006-09-01 |
| Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria (NCT00371735) | GlaxoSmithKline | 2006-04-01 |
| Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen (NCT00408668) | University of Oxford | 2005-08-01 |
| A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia. (NCT00157885) | Menzies School of Health Research | 2005-07-01 |
| Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine (NCT00223990) | U.S. Army Medical Research and Development Command | 2005-04-08 |
| Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi (NCT00164359) | Centers for Disease Control and Prevention | 2005-04-01 |
| Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi (NCT00164710) | Centers for Disease Control and Prevention | 2005-04-01 |
| Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in Peru (NCT00164216) | Centers for Disease Control and Prevention | 2005-03-01 |
| The Community Effectiveness of IPTi in Southern Tanzania (NCT00152204) | Swiss Tropical & Public Health Institute | 2005-03-01 |
| Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria (NCT00147368) | Menzies School of Health Research | 2005-02-01 |
| Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education. (NCT00142246) | London School of Hygiene and Tropical Medicine | 2005-01-01 |
| Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum (NCT00082563) | Pfizer | 2004-08-01 |
| Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America (NCT00084227) | Pfizer | 2004-07-01 |
| Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa (NCT00082576) | Pfizer | 2004-06-01 |